Voya Investment Management LLC Eiger Bio Pharmaceuticals, Inc. Transaction History

Voya Investment Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.89 - $2.52 $4,336 - $12,279	4,873 Added 30.24%	20,985 $18,000
Q2 2022 Aug 15, 2022	BUY	$4.99 - $8.96 $13,632 - $24,478	2,732 Added 20.42%	16,112 $102,000
Q4 2021 Feb 14, 2022	SELL	$5.12 - $8.19 $2,534 - $4,054	-495 Reduced 3.57%	13,380 $69,000
Q1 2021 May 17, 2021	SELL	$8.44 - $12.66 $90,063 - $135,094	-10,671 Reduced 43.47%	13,875 $123,000
Q4 2020 Feb 16, 2021	BUY	$7.98 - $12.29 $49,324 - $75,964	6,181 Added 33.66%	24,546 $302,000

Q3 2020 Nov 16, 2020	BUY	$7.96 - $12.42 $146,185 - $228,093	18,365 New	18,365 $149,000
Q2 2020 Aug 14, 2020	SELL	$5.4 - $13.37 $61,003 - $151,040	-11,297 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$9.77 - $15.66 $110,371 - $176,911	11,297 New	11,297 $168,000

748K

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $490M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.